Dagajas, Ashira Adiya P.
HRN: 21-35-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/30/2022
12/07/2022
IVT
300 Mg
8 Hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes